The European Commission has reimbursed Malta almost € 14 million for some of the COVID vaccines that the country acquired by mid-November last year.
An official statement from the city’s representative office in the City said the grant was worth € 13,810,622.
By May last year, the government had already spent almost € 100 million on vaccines.
The EU office said that, at the beginning of 2020, Malta was one of the countries pushing for a joint procurement by the European Commission, including funding for the eventual development of COVID-19 vaccines.
As soon as the vaccines became available, and later approved by the EMA, Malta was able to obtain enough vaccines to cover the entire population.
Both morbidity and mortality have decreased over time as vaccination has progressed to cover virtually the entire population.
At the end of 2020, Malta’s positivity and mortality rates were high
At the end of 2020, Malta’s positivity and mortality rates were high. The decline in these rates seen a few months later is attributed to the partial lockout called on 10 March 2021 and rising vaccination rates.
The report said that Malta administered at least 1,233,948 doses of COVID-19 vaccines, with low hesitation about vaccination and vaccine availability being two key factors in this success.
Freelance journalism costs money. Times of Malta Support for price of coffee.